AD26-like DNA repair protein (RAD26L), encoded by the ATXN3L gene in humans, is a protein involved in DNA damage repair. Its name comes from its similarity to the yeast RAD26 protein, which is known for its role in DNA repair and transcription.RAD26L belongs to the Josephin family of proteins, which are characterized by the presence of a Josephin domain. This domain is primarily found in proteins involved in ubiquitin-dependent proteolysis, a process that helps maintain cellular homeostasis by degrading unnecessary or damaged proteins.
In addition to its role in DNA repair, RAD26L is also implicated in transcription-coupled nucleotide excision repair (TC-NER), a pathway that removes DNA damage specifically from the transcribed strand of active genes. This process ensures that the genetic information being actively transcribed into RNA is accurate, inhibiting he generation of potentially harmful proteins.Its involvement in DNA repair and maintenance of genomic integrity suggests that it could be important in inhibiting the development of cancer and other diseases associated with DNA damage.Further research will provide a better understanding of the specific functions and importance of RAD26L in human biology, and could potentially reveal new targets for Intervention in diseases associated with DNA damage and repair.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $138.00 $380.00 | 101 | |
Cisplatin induces DNA damage, potentially activating DNA repair pathways including those involving ERCC6L2. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $51.00 $231.00 $523.00 | 63 | |
Etoposide causes DNA damage by inhibiting topoisomerase II, potentially influencing ERCC6L2-related repair mechanisms. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
Camptothecin inhibits topoisomerase I, inducing DNA damage and possibly impacting ERCC6L2 functions. | ||||||
Hydroxyurea | 127-07-1 | sc-29061 sc-29061A | 5 g 25 g | $78.00 $260.00 | 18 | |
Hydroxyurea inhibits ribonucleotide reductase, causing DNA replication stress and potentially affecting ERCC6L2. | ||||||
Methyl methanesulfonate | 66-27-3 | sc-250376 sc-250376A | 5 g 25 g | $56.00 $133.00 | 2 | |
MMS is an alkylating agent that causes DNA damage, potentially activating ERCC6L2-mediated repair pathways. | ||||||
Olaparib | 763113-22-0 | sc-302017 sc-302017A sc-302017B | 250 mg 500 mg 1 g | $210.00 $305.00 $495.00 | 10 | |
Olaparib, a PARP inhibitor, could indirectly affect ERCC6L2 by altering DNA repair pathways. | ||||||
Bleomycin | 11056-06-7 | sc-507293 | 5 mg | $275.00 | 5 | |
Bleomycin induces DNA breaks, potentially activating nucleotide excision repair pathways involving ERCC6L2. | ||||||